Bioinformatics methods in drug repurposing for Alzheimer's disease.
about
A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mappingNLRP12 Inflammasome Expression in the Rat Brain in Response to LPS during Morphine Tolerance.Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis.KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.Identifying new antiepileptic drugs through genomics-based drug repurposing.Genome-Wide Expression Profiles Drive Discovery of Novel Compounds that Reduce Binge Drinking in Mice.
P2860
Bioinformatics methods in drug repurposing for Alzheimer's disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@ast
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@en
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@nl
type
label
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@ast
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@en
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@nl
prefLabel
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@ast
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@en
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Bioinformatics methods in drug repurposing for Alzheimer's disease.
@en
P2093
George M Spyrou
John C Siavelis
Konstantina S Nikita
Marilena M Bourdakou
P2860
P304
P356
10.1093/BIB/BBV048
P577
2015-07-21T00:00:00Z